文章

2006年8月14日

Interfaith Center on Corporate Responsibility [USA]

New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

The Interfaith Center on Corporate Responsibility released a comprehensive scorecard evaluating the pharmaceutical industry's efforts in the fight against HIV/AIDS...The ICCR report highlights the large disparities between industry best practices in addressing...HIV/AIDS...and the current actions of 15 leading pharmaceutical companies. "We see two major problems - a failure to develop new medicines that address neglected diseases and a lack of access for poor patients to the existing medicines," said Daniel Rosan, ICCR's Program Director for Public Health and author of the report... [companies rated: Abbott Laboratories, AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Gilead Sciences, Johnson & Johnson, Eli Lilly, Merck, Novartis, Pfizer, Hoffmann-La Roche (part of Roche), sanofi-aventis, Schering-Plough, Wyeth]

时间线

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

日期:

2014年3月4日

内容类型:

企业回应

适用语言: English
[PDF] Benchmarking AIDS: 2006 Year End Update

日期:

2006年11月30日

内容类型:

文章

适用语言: English
Response by Merck: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Merck - finds none has comprehensive approach.

日期:

2006年9月13日

内容类型:

企业回应

适用语言: English
Response by Wyeth (part of Pfizer): Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Wyeth - finds none has comprehensive approach.

日期:

2006年9月13日

内容类型:

企业回应

适用语言: English
Response by Bristol-Myers Squibb: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Bristol-Myers Squibb - finds none has comprehensive approach.

日期:

2006年9月13日

内容类型:

企业回应

适用语言: English
Company responses to Interfaith Center on Corporate Responsibility report "Benchmarking AIDS"

日期:

2006年9月12日

内容类型:

文章

适用语言: English
Response by Boehringer Ingelheim: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Boehringer-Ingelheim - finds none has comprehensive approach.

日期:

2006年9月6日

内容类型:

企业回应

适用语言: English
Response by AstraZeneca: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including AstraZeneca - finds none has comprehensive approach.

日期:

2006年9月6日

内容类型:

企业回应

适用语言: English
Reclaman mayor compromiso de las farmacéuticas

日期:

2006年8月31日

内容类型:

文章

适用语言: español
Eli Lilly did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Eli Lilly - finds none has comprehensive approach.

日期:

2006年8月23日

内容类型:

企业回应

适用语言: English
Response by Pfizer: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Pfizer - finds none has comprehensive approach.

日期:

2006年8月23日

内容类型:

企业回应

适用语言: English
Response by Novartis: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Novartis - finds none has comprehensive approach.

日期:

2006年8月23日

内容类型:

企业回应

适用语言: English
International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

日期:

2006年8月17日

内容类型:

文章

适用语言: English
[PPT] presentation: "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"

日期:

2006年8月17日

内容类型:

文章

适用语言: English
New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

日期:

2006年8月14日

内容类型:

文章

适用语言: English
Sanofi-Aventis did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including sanofi-aventis - finds none has comprehensive approach.

日期:

2006年8月1日

内容类型:

企业回应

适用语言: English
Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

日期:

2006年8月1日

内容类型:

企业回应

适用语言: English
Hoffmann-La Roche (part of Roche) did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Hoffman-La Roche - finds none has comprehensive approach.

日期:

2006年1月8日

内容类型:

企业回应

适用语言: English
Gilead Sciences did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Gilead - finds none has comprehensive approach.

日期:

2006年1月8日

内容类型:

企业回应

适用语言: English

浏览完整时间线

加载更多显示更少

Business & Human Rights
Resource Centre

《中国海外负责任投资快讯》第三十三期2024年10月：乌干达：政府继续镇压针对东非原油管道项目的抗议活动；调查报告指附属管道项目的翠鸟油田存在与军队和安全部队有关的大规模侵犯人权问题

企业法律责任季度简报- 2024年9月第 50 期: 支持强制监管的理由: 司法判例表明科技行业不能停留在自我监管层面

企业责任资源中心

《中国海外负责任投资快讯》第三十三期2024年10月：乌干达：政府继续镇压针对东非原油管道项目的抗议活动；调查报告指附属管道项目的翠鸟油田存在与军队和安全部队有关的大规模侵犯人权问题

企业法律责任季度简报- 2024年9月第 50 期: 支持强制监管的理由: 司法判例表明科技行业不能停留在自我监管层面

这页面没有简体中文版本，现以English显示

New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

时间线

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

[PDF] Benchmarking AIDS: 2006 Year End Update

Response by Merck: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Merck - finds none has comprehensive approach.

Response by Wyeth (part of Pfizer): Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Wyeth - finds none has comprehensive approach.

Response by Bristol-Myers Squibb: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Bristol-Myers Squibb - finds none has comprehensive approach.

Company responses to Interfaith Center on Corporate Responsibility report "Benchmarking AIDS"

Response by Boehringer Ingelheim: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Boehringer-Ingelheim - finds none has comprehensive approach.

Response by AstraZeneca: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including AstraZeneca - finds none has comprehensive approach.

Reclaman mayor compromiso de las farmacéuticas

Eli Lilly did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Eli Lilly - finds none has comprehensive approach.

Response by Pfizer: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Pfizer - finds none has comprehensive approach.

Response by Novartis: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Novartis - finds none has comprehensive approach.

International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

[PPT] presentation: "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"